-
EFTR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
eFFECTOR Therapeutics (EFTR)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 15.51 mm | 15.51 mm | 15.51 mm | 15.51 mm | 15.51 mm | 15.51 mm |
Cash burn (monthly) | (no burn) | (no burn) | 2.80 mm | 2.73 mm | 2.43 mm | 2.43 mm |
Cash used (since last report) | n/a | n/a | 28.67 mm | 27.92 mm | 24.86 mm | 24.92 mm |
Cash remaining | n/a | n/a | -13.17 mm | -12.41 mm | -9.35 mm | -9.41 mm |
Runway (months of cash) | n/a | n/a | -4.7 | -4.6 | -3.9 | -3.9 |
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 0 |
Closed positions | 27 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 106.76 mm |
Total shares | 11.95 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
SR One Capital Management | 6.82 mm | $56.49 mm |
Altitude Life Science Ventures Fund II | 2.83 mm | $47.99 mm |
PFE Pfizer | 2.24 mm | $0.00 |
Sabby Management | 61.76 k | $2.29 mm |
BCS Barclays | 100.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 24 | Bhatt Elizabeth | Stock Option Common Stock | Grant | Acquire A | No | No | 1.38 | 800 | 1.10 k | 800 |
13 Jun 24 | Brian M. Jr. Gallagher | Stock Option Common Stock | Grant | Acquire A | No | No | 1.38 | 800 | 1.10 k | 800 |
13 Jun 24 | Kristen Harrington-Smith | Stock Option Common Stock | Grant | Acquire A | No | No | 1.38 | 800 | 1.10 k | 800 |
13 Jun 24 | Christopher B Ehrlich | Stock Option Common Stock | Grant | Acquire A | No | No | 1.38 | 800 | 1.10 k | 800 |
13 Jun 24 | Barbara Klencke | Stock Option Common Stock | Grant | Acquire A | No | No | 1.38 | 800 | 1.10 k | 800 |